1. Introduction {#sec1}
===============

Mycotoxins are secondary metabolites of molds which are associated with certain disorders in animals and humans. In addition to being acutely toxic, some mycotoxins are now linked with the incidence of certain types of cancer, and it is this aspect which has evoked global concern over feed and food safety, especially for milk and milk products \[[@B1]\]. Aflatoxin M~1~ (AFM~1~) is a hepatocarcinogen found in milk of animals that have consumed feeds contaminated with aflatoxin B1 (AFB1), the main metabolite produced by fungi of the genus *Aspergillus,* particularly *A. flavus, A. parasiticus,* and *A. nomius* \[[@B2]\]. About 0.3--6.2% of AFB1 in animal feed is transformed to AFM~1~ in milk \[[@B3]\]. Due to serious health concerns, many countries have set maximum limits for aflatoxins, which vary from country to country \[[@B4]\]. The European Community prescribes that the maximum level of AFM~1~ in liquid milk should not exceed 50 ppt. However, according to the US standard, the level of AFM~1~ in liquid milk should not be higher than 500 ppt \[[@B5]\]. There have been several studies on AFM~1~ concentration in milk samples in different regions of the world and also in Iran, but this study was done to evaluate the occurrence of AFM~1~ in milk distributed in Mashad in northeast of Iran in order to evaluate the potential of changing the regional standard on AFM~1~ contamination of milk.

2. Materials and Methods {#sec2}
========================

2.1. Materials {#sec2.1}
--------------

### 2.1.1. Samples {#sec2.1.1}

In this study the AFM~1~ content of pasteurized milk samples in retail stores in Mashad (northeast of Iran) was determined in fall 2011. Forty-two pasteurized milk samples (1000 mL milk packets, heat treated at 72--74.4Ć for 15--20′′) from different brands were collected by simple random sampling method. The samples were transported to the laboratory in an insulated container at about 4°C and analyzed upon arrival.

### 2.1.2. Reagents {#sec2.1.2}

Most of the reagents used to detect AFM~1~ were contained in the RIDASCREEN test kit, which included microtiter plate coated with capture antibodies, AFM~1~ standard solutions used for the construction of the calibration curve (1.3 mL each 0, 5, 10, 20, 40, and 80 ppt), peroxidase-conjugated AFM~1~, substrate (urea peroxidase), chromogen (tetramethylbenzidine), and stop reagent contains 1N sulphuric acid. Methanol used was of analytical grade and provided by Merck.

2.2. Methods {#sec2.2}
------------

### 2.2.1. AFM~1~ Detection {#sec2.2.1}

The quantitative analysis of AFM~1~ in pasteurized milk samples was performed by competitive ELISA (RIDASCREEN AFM~1~, R-Biopharm) procedure as described by R-biopharm GmbH \[[@B6]\]. Prior to analysis of the samples, the ELISA method was validated to ensure data quality. Validation of ELISA was carried out by determination of recoveries and the mean variation coefficient for fresh milk spiked with different concentrations of AFM~1~ (5, 10, 20, 40 and 80 ppt). The results are expressed in [Table 1](#tab1){ref-type="table"}.

Milk samples were centrifuged at 3500 g for 10 min at 10°C. The upper creamy layer was completely removed by aspirating through a Pasteur pipette and from the lower phase (defatted phase) 100 *μ*L was directly used per well in the test. One hundred *μ*L of the AFM~1~ standard solutions (100 *μ*L/well) and test samples (100 *μ*L/well) in duplicate were added to the wells of microtiter plate and incubated for 60 min at room temperature in the dark. After the washing steps, 100 *μ*L of the enzyme conjugate was added and incubated for 60 min at room temperature in the dark. The washing step was repeated three times. Fifty *μ*L of substrate and 50 *μ*L of chromogen were added to each well and mixed thoroughly and incubated for 30 min in the dark. Following the addition of 100 *μ*L of the stop reagent to each well, the absorbance was measured at 450nm in ELISA reader (ELX-800, Bio-Tek Instruments, USA). According to the RIDASCREEN kit guidelines, the lower detection limit is 5 ppt for milk.

### 2.2.2. Evaluation of AFM~1~ {#sec2.2.2}

The absorbance values obtained for the standards and the samples were divided by the absorbance value of the first standard (zero standards) and multiplied by 100 (percentage maximum absorbance). Therefore, the zero standard is thus made equal to 100%, and the absorbance values are quoted in percentages. The values calculated for the standards were entered in a system of coordinates on semilogarithmic graph paper against the AFM~1~ concentration in ppt ([Figure 1](#fig1){ref-type="fig"}). The equation of the trendline in [Figure 1](#fig1){ref-type="fig"} is as follows: $$\begin{matrix}
{y = 0.016x^{2} - 1.940x + 91.34.} \\
\end{matrix}$$

3. Statistical Analysis {#sec3}
=======================

Data were analysed using Excel 2007 and results reported as mean ± SD. The calibration curve and trendline equation prepared using Excel 2007.

4. Results and Discussion {#sec4}
=========================

The standard solutions of concentration from 5 to 80 ppt AFM~1~ were used to find calibration/standard curve. The results showed the linearity of the standard curve over the range studied. [Figure 1](#fig1){ref-type="fig"} gives the calibration curve of standard solutions of AFM~1~ with concentrations of 5, 10, 20, 40, and 80 ppt by ELISA analysis.

Analytical results showed that the incidence of AFM~1~ contamination in pasteurized milk samples was low. Although 97.6% of the samples were contaminated with AFM~1,~ the toxin concentration was lower than Iranian national standard and FDA limit (500 ppt) and only in three (1.6%) of the samples AFM~1~ concentration was greater than the maximum tolerance limit (50 ppt) accepted by European Union and Codex Alimentarius Commission. [Table 2](#tab2){ref-type="table"} shows the distribution and percentage of AFM~1~ contamination in pasteurized milk samples. The minimum and maximum contamination level of AFM~1~ was found to be 6.4 and 71.4 ppt, respectively. The mean ± SD AFM~1~ level in the analyzed samples of pasteurized milk was 23 ± 16 ppt.

The mean AFM~1~ concentrations in milk in European, Latin American, and Far Eastern diets have been reported by the Joint FAO/WHO Expert Committee on Food Additives \[[@B7]\] to be 23, 22, and 360 ng/L, respectively. Thus, the observed mean AFM~1~ concentration in Mashad milk samples was as high as the European and Latin American and much lower than those reported for the Far Eastern diets.

On the other hand, several studies have been done to determine AFM~1~ contamination of milk in Iran ([Table 3](#tab3){ref-type="table"}). The incidence of AFM~1~ observed in the present study was lower than the incidence of AFM~1~ reported by other authors \[[@B8]--[@B17]\], yet, in all studies, the averages of toxin concentrations are below 100 ppt. The variations may be attributed to differences in region, season, and especially analysis method.

Based on the above results, especially later studies in Mashad, the present situation is hopeful and might represent the possibility of altering standard limit of AFM~1~ concentration in milk in Iran. We suggest reduction of the limit as low as 100 ppt for raw milk.

The authors declare that there is no conflict of interests.

The authors acknowledge funding support for this study by Mashad University of Medical Sciences.

![Calibration curve of standard solutions of AFM~1~ with concentrations of 5, 10, 20, 40, and 80 ppt by ELISA analysis.](ISRN.TOXICOLOGY2012-121926.001){#fig1}

###### 

Validation data of the competitive ELISA for AFM~1~.

  -----------------------------------------------------------------------------------
  AFM~1~ spiked (ppt)\   AFM~1~ found (ppt)   Recovery\   Variation coefficient (%)
  (*n* = 5)                                   (%)         
  ---------------------- -------------------- ----------- ---------------------------
  5                      5                    100         0.0

  10                     9.98                 99.8        0.2

  20                     20.11                100.55      0.5

  40                     39.84                99.60       0.4

  80                     79.90                99.87       0.1
  -----------------------------------------------------------------------------------

###### 

Aflatoxin M1 distribution and percentage of pasteurized milk samples.

  AFM~1~ levels ppt in positive samples                              
  --------------------------------------- ------ ------ ------ ----- -----
  *N* ^1^                                 5      27     5      3     1
  \%^2^                                   12.3   65.6   12.3   7.4   2.4

*N* ^1^ number of contaminated samples.

\%^2^ Percentage of AFM~1~ positive samples.

^∗^71.3 ppt in the contaminated sample.

###### 

The incidence of milk contamination in Iran in other studies.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------
  Location                       Reference                                    Method of\   Sample\   Percent of\     Percent of\              AFM~1~  \
                                                                              detection    size      contamination   contamination \>50 ppt   concentration (ppt)
  ------------------------------ -------------------------------------------- ------------ --------- --------------- ------------------------ ---------------------
  Mashad (north east of Iran)    Current study                                ELISA        42        97.6            1.6                      23.2

  Mashad (north east of Iran)    Mohamad Sani and Nikpooyan, 2012 \[[@B8]\]   HPLC         60        100             1.6                      16.16

  Mashad (north east of Iran)    Mohamadi Sani et al., 2010 \[[@B9]\]         ELISA        196       100             80.6                     77.9

  Five states of Iran            Tajkarimi et al., 2007 \[[@B10]\]            HPLC         98        100             37.7                     39

  Tehran (capital of Iran)       Heshmati and Milani, 2010 \[[@B17]\]         ELISA        210       55.2            33.3                     58

  14 states of Iran              Tajkarimi et al., 2008 \[[@B13]\]            HPLC         319       54              23                       57

  Shiraz (south of Iran)         Alborzi et al., 2006 \[[@B12]\]              ELISA        624       100             17.8                     n.r\*

  Ahwaz (south of Iran)          Rahimi et al., 2010 \[[@B16]\]               ELISA        311       42.1            12.5                     43.3

  Sarab (north west of Iran)     Kamkar 2005 \[[@B11]\]                       TLC          111       76.6            40                       61.4

  Central part of Iran           Fallah 2010 \[[@B14]\]                       ELISA        225       67.1            33.1                     49.9

  Ardabil (north west of Iran)   Nemati et al., 2010 \[[@B15]\]               ELISA        90        100             33                       n.r\*
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------

^∗^Not reported.
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